Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Padova, Inst Res BiomedicinefiledCriticalUniv Of Padova
Publication of AR124616A1publicationCriticalpatent/AR124616A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Métodos y composiciones para modificar el curso y severidad de trastornos neuropsiquiátricos. El método incluye administrar una composición a un sujeto que sufre de un trastorno neuropsiquiátrico, caracterizado porque la composición incluye una sustancia seleccionada de dextrometadona, metabolitos de dextrometadona, d-metadol, d-a-acetilmetadol, d-a-normetadol, l-a-normetadol, así como las sales de los mismos aceptables desde el punto de vista farmacéutico.Methods and compositions to modify the course and severity of neuropsychiatric disorders. The method includes administering a composition to a subject suffering from a neuropsychiatric disorder, characterized in that the composition includes a substance selected from dextromethadone, dextromethadone metabolites, d-methadol, d-a-acetylmethadol, d-a-normethadol, l-a-normethadol, as well as the pharmaceutically acceptable salts thereof.
ARP210100004A2020-01-032021-01-04
DEXTROMETADONE AS A DISEASE MODIFYING THERAPY FOR NEUROPSYCHIATRIC DISORDERS AND DISORDERS
AR124616A1
(en)